NCT00154700View on ClinicalTrials.gov

Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

July 31, 2005

Conditions
Esophageal Cancer
Interventions
DRUG

Paclitaxel,Cisplatin,5-Fu,Folic Acid

Trial Locations (1)

100

Department of Oncology, National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT00154700 - Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer | Biotech Hunter | Biotech Hunter